Midazolam decreases cerebral blood flow in the left prefrontal cortex in a dose-dependent fashion
Abstract:
Midazolam, a short-lived benzodiazepine producing sedation and reversible anterograde amnesia, was administered intravenously to 14 healthy male volunteers. Regional cerebral blood flow (rCBF) was measured using positron emission tomography (PET) with intravenous H2 15O at either a 'high' midazolam EEG effect (EEG signs of stage 2 sleep), or 'low' midazolam EEG effect (increase in EEG beta power only). Memory tests administered following PET scans showed significant drug-induced impairment in learning and retrieval at the same drug concentration at which PET images were acquired. Statistical parametric mapping was used to identify regions where rCBF changes after drug administration were significantly different in the high- vs. low- effect groups. Dosexcondition interactions were found in the left dorsolateral prefrontal cortex [Brodmann's areas (BA) 9 and 46], bilateral orbital-frontal cortex (BA 47), the left middle temporal gyrus (BA 22) and the right hippocampus. The predominantly left frontal rCBF decreases occur in a region associated with semantic processing, working memory, and encoding of verbal material, a process preferentially affected by midazolam. Our interpretation is that rCBF changes in the hippocampus are unlikely to mediate the anterograde amnesia produced by midazolam. Although in the present study PET images were acquired during the resting state rather than during memory processing, these results underscore the need for further investigation relating to the interaction of midazolam with specific cognitive operations in these brain regions.
Insights
Midazolam impairs memory by altering blood flow in key brain regions like the prefrontal cortex. These changes in regional cerebral blood flow (rCBF) are linked to memory deficits, but not directly to hippocampal activity.
Area of Science:
- Neuroscience
- Pharmacology
- Cognitive Science
Background:
- Midazolam is a short-acting benzodiazepine known for sedation and amnesia.
- Understanding midazolam's effects on brain activity and cognition is crucial for its clinical application.
Purpose of the Study:
- To investigate the effects of midazolam on regional cerebral blood flow (rCBF) in relation to its cognitive effects, specifically anterograde amnesia.
- To identify specific brain regions affected by different levels of midazolam's central nervous system activity.
Main Methods:
- Intravenous administration of midazolam to healthy male volunteers.
- Measurement of regional cerebral blood flow (rCBF) using positron emission tomography (PET) with H2 15O.
- Assessment of memory function (learning and retrieval) and electroencephalogram (EEG) to determine drug effect levels.
- Statistical parametric mapping to analyze differences in rCBF between high and low midazolam effect groups.
Main Results:
- Significant drug-induced impairment in learning and retrieval was observed.
- Dose-condition interactions revealed decreased rCBF in the left dorsolateral prefrontal cortex, orbital-frontal cortex, left middle temporal gyrus, and right hippocampus.
- Predominantly left frontal rCBF decreases were associated with semantic processing and working memory functions.
Conclusions:
- Midazolam-induced anterograde amnesia is associated with reduced rCBF in specific frontal and temporal brain regions involved in memory processing.
- Hippocampal rCBF changes are unlikely to be the primary mechanism mediating midazolam's amnesic effects.
- Further research is needed to explore the interaction between midazolam and cognitive operations in affected brain regions, even during resting states.
More Related Videos
09:26Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
Published on: February 6, 2019
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
Related Concept Videos
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:14CNS Depressants: Barbiturates and Benzodiazepines
01:23Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
01:20Sedatives and Hypnotics Drugs: Barbiturates